Programme 201728 - 29 September, 2017–Santiago de Compostela, Spain

11th Annual TTS Europe Santiago de Compostela, Spain, 28-29 Sept. 2017

Day 1 08:30 Registration & Coffee 09:00 Official Opening, Welcome & Introduction

– Opening remarks: Christian J. Suojanen, Co-Founder/Chairman, TTS Global Initiative – Welcome Remarks:

1. Jesus Vazquez Almuiña, Conselleiro de Sanidade, Government of Galicia 2. Patricia Argerey, Director, Galician Innovation Agency (GAIN)

09:30 Keynote 1: Partnering with Boehringer-Ingehleim

– Clive Long, Vice President, NBE Discovery at Boehringer Ingelheim, Germany

10:00 The Innovation Eco-system: Learning from & localizing global best practices in facilitating the development of a thriving biotech sector. – Moderator: Lorena Muñoz, Managing Director, Effectia Consulting, Madrid, Spain – Sergio Figueiras, ACIS, Galician Health Knowledge Agency – Carme Pampin, BIOGA, Cluster Ciencias de la Vida – Phil Jackson, Projects Director, MedCity, London, UK – Albert Barbera, Director General, Research & Innovation in Health, Generalitat de Catalunya, Barcelona, Spain – Mabel Loza, Head, Founding Member & Scientific Director, Kaerto Foundation, A Coruña, Spain

11:00 Coffee & Networking Breakout 11:30 UTILE: Exploiting the hidden gems from the largest pan-EU portfolio analysis ever conducted.

– 11:30: UTILE: Lieke Geris, Senior Consultant, Life Sciences & Health, PNO Consultants, The Netherlands – 11:40 Mining for gold – WP2 Portfolio evaluation: LifeArc (MRC Technology), London, UK

12:00 IP & Patent Law: What is happening now and what does it mean for your company’s business model

or your institution’s IP portfolio? Global strategies to enable your business model, financing and deal-making. – Kevin Noonan, Partner, MBHB LLP, Editor & Co-Founder, Patent Docs, Chicago, USA

Discussion Panel – Kevin Noonan, Partner, MBHB LLP, Editor & Co-Founder, Patent Docs, Chicago, USA – Dmitry Vinarov, Partner, MBHB LLP, Chicago, USA

13:00 Networking Lunch

11th Annual TTS Europe Santiago de Compostela, Spain, 28-29 Sept. 2017

Day 1 continued 14:00 Business Development for Tech Transfer & Early stage biotech.

– Mats Ferm, Innovation Officer, Karolinska Institutet Innovation AB, Stockholm, Sweden – Anders Haugland – CEO, Bergen Teknologioverføring AS, Bergen, Norway – Sigrid Scheek, Technology Manager, Ascenion GmbH, Munich, Germany – Steve Ferguson, Deputy Director, Licensing & Entrepreneurship, Office of Technology Transfer, National

Institutes of Health (NIH), USA – Álvaro Díez Díaz, Business Development Manager (Technology Transfer Department), Pons IP, Madrid, Spain

15:00 Co-Development Collaborations: Partnerships to hit critical inflection points and become “deal

ready.” – Dave Pardoe, Associate Director & Head of Innovation & Initiatives, LifeArc (MRC Technology), London, UK

15:20 Your market & customer: What the healthcare industry is seeking for from research, clinicians

and early stage companies; what they need and what drives deals. – Jay McGill, Senior Director, External Innovation, Science & Technology Partnerships, Lilly Research

Laboratories, Indianapolis, Indiana, USA – Oliver Chao, Head of Emerging Biomedical Sciences, Responsible Partenariats, Sanofi, Paris, France – Dave Pardoe, Associate Director & Head of Innovation & Initiatives, LifeArc (MRC Technology), London, UK – Cecilia Prego, Director of Technical Services, CZVeterinaria – Biofabri, Galicia, Spain

16:00 Coffee & Networking Breakout 16:30 Publicly listed VC funds to change the landscape & address the financing valley of death im biotech. Daniel Bach, Director, Healthcare Ventures, Touchstone (Imperial) Innovations, London, UK

17:00 Financing biotech start-ups & SMEs in Europe today, with a view to follow up and cross-border

investments and an eventual exit. – Daniel Bach, Director, Healthcare Ventures, Touchstone (Imperial) Innovations, London, UK – Laia Crespo, Investment Director, Ysios Capital, Barcelona, Spain – Damia Tormo, General Partner, Columbus Partners Capital. Madrid, Spain – Juan Garcia Soria, CEO, BioSeed Capital, Barcelona, Spain – Yolanda Falcon, Unirisco/Uninvest, Galician Capital Risc

18:00 Thoughts for discussion – TTS Global Initiative Closing Remarks – Luis Leon, ACIS, Galician Health Knowledge Agency 18:45 **Networking Wine & Tapas Reception, Museo Centro Gaiás**

11th Annual TTS Europe Santiago de Compostela, Spain, 28-29 Sept. 2017

Day 2 08:30 Registration & Coffee 09:00 Opening remarks

09:15 Technology Transfer & Entrepreneurship lessons learned at the National Institutes of Health.

– Steve Ferguson, Deputy Director, Licensing & Entrepreneurship, Office of Technology Transfer, National Institutes of Health (NIH), USA

10:00 What Brexit means for EU biotech: Implications for you IP, fund-raising, EU funded consortia, collaborations, licensing & royalties, and more. – Sally Shorthose, Partner, Bird & Bird, UK

11:00 Coffee & Networking Breakout 11:30 Early stage innovation and industry-academia collaboration

– J.Luis Villaverde, Oficina de transferencia de la Universidad de Santiago Compostela – Oliver Chao, Oliver Chao, Head of Emerging Biomedical Sciences, Responsible Partenariats, Sanofi, Paris,

France – Steve Ferguson, Deputy Director, Licensing & Entrepreneurship, Office of Technology Transfer, National

Institutes of Health (NIH), USA – Aurora Berra de Unamuno, Formerly VP Head of Medical, Intercontinental Region, Bristol-Myers Squibb

12:30 Closing Discussion – Patricia Argerey, Directora, Galician Health Innovation Agency (GAIN) – Clive Long, Vice President, NBE Discovery at Boehringer Ingelheim, Germany

– Aurora Berra de Unamuno, Formerly VP Head of Medical, Intercontinental Region, Bristol-Myers Squibb – Kevin Noonan, Partner, MBHB LLP, Editor & Co-Founder, Patent Docs, Chicago, USA – Sally Shorthose, Partner, Bird & Bird, UK

13:00 Networking Lunch reception